Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.7 |
mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |